| |
| |
|
| Insider
Information: |
Konstantinov Konstantin |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,220 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$193,199 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,220 |
|
|
| Total
Value |
$193,199 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Codiak Biosciences, Inc. |
CDAK |
|
2023-03-28 |
0 |
2021-06-08 |
0 |
Premium* |
|
|
Repligen Corp |
RGEN |
Director |
2023-05-18 |
1,220 |
2022-05-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGEN |
Repligen Corp |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
686 |
1,220 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2023-03-28 |
4 |
S |
$0.20 |
$1,874 |
D/D |
(9,364) |
0 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2023-02-17 |
4 |
S |
$0.59 |
$824 |
D/D |
(1,391) |
7,432 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,200 |
8,823 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2023-01-20 |
4 |
S |
$0.58 |
$615 |
D/D |
(1,069) |
1,731 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2023-01-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
2,800 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2022-08-17 |
4 |
S |
$2.21 |
$2,894 |
D/D |
(1,308) |
4,623 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,200 |
5,931 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
534 |
534 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2021-06-08 |
4 |
AS |
$25.53 |
$186,276 |
D/D |
(7,276) |
0 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Chief Technology Officer |
• – – |
2021-06-08 |
4 |
OE |
$3.29 |
$23,938 |
D/D |
7,276 |
7,276 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
